| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20052584 | HPV | ENSG00000166123.14 | protein_coding | GPT2 | No | No | 84706 | Q8TD30 |
| TVIS44021026 | HTLV-1 | ENSG00000166123.14 | protein_coding | GPT2 | No | No | 84706 | Q8TD30 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GPT2 |
|---|---|
| DrugBank ID | DB00780 |
| Drug Name | Phenelzine |
| Target ID | BE0002166 |
| UniProt ID | Q8TD30 |
| Regulation Type | inhibitor |
| PubMed IDs | 19203467; 11775064; 1881457 |
| Citations | Todd KG, Baker GB: Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. J Pharm Pharm Sci. 2008 May 16;11(2):14s-21s.@@Tanay VA, Parent MB, Wong JT, Paslawski T, Martin IL, Baker GB: Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cell Mol Neurobiol. 2001 Aug;21(4):325-39.@@McKenna KF, Baker GB, Coutts RT: N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines. Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):478-82. |
| Groups | Approved |
| Direct Classification | Benzene and substituted derivatives |
| SMILES | NNCCC1=CC=CC=C1 |
| Pathways | |
| PharmGKB | PA450903 |
| ChEMBL | CHEMBL1089 |
